Matt TurnerPatient Affordability
Joey CohenMedication Adherence
Suma Ramadas, PhDMedical Affairs
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Liz KaneImpactful Strategy
Brenda SnowAuthentic Patient Voice
Pat PurcellMeeting Engagement
David LinetskyPoint-of-Care Marketing
Daniel SontupeMarket Access
Matthew DurhamOmnidynamic Marketing
Bud BilanichSuccess Coach
Frank BurrellScientific Storytelling
Paul TheisenPatient Acquisition
RANCHO CORDOVA, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL), ...
Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email